CN101062361A - Chinese traditional medicine for treating dermatosis and its preparation method - Google Patents
Chinese traditional medicine for treating dermatosis and its preparation method Download PDFInfo
- Publication number
- CN101062361A CN101062361A CN 200710011491 CN200710011491A CN101062361A CN 101062361 A CN101062361 A CN 101062361A CN 200710011491 CN200710011491 CN 200710011491 CN 200710011491 A CN200710011491 A CN 200710011491A CN 101062361 A CN101062361 A CN 101062361A
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- rhizoma
- chinese medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 208000017520 skin disease Diseases 0.000 title abstract description 10
- 206010048768 Dermatosis Diseases 0.000 title description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims description 42
- 239000009636 Huang Qi Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 11
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 229940126678 chinese medicines Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000758993 Equisetidae Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 33
- 206010053615 Thermal burn Diseases 0.000 description 27
- 208000027418 Wounds and injury Diseases 0.000 description 18
- 206010052428 Wound Diseases 0.000 description 16
- 206010017553 Furuncle Diseases 0.000 description 15
- 201000004624 Dermatitis Diseases 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 206010063409 Acarodermatitis Diseases 0.000 description 12
- 241000447727 Scabies Species 0.000 description 12
- 201000007227 lymph node tuberculosis Diseases 0.000 description 12
- 208000005687 scabies Diseases 0.000 description 12
- 208000032843 Hemorrhage Diseases 0.000 description 11
- 208000007514 Herpes zoster Diseases 0.000 description 11
- 208000010668 atopic eczema Diseases 0.000 description 11
- 206010025135 lupus erythematosus Diseases 0.000 description 11
- 206010040872 skin infection Diseases 0.000 description 11
- 239000002574 poison Substances 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 206010000269 abscess Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 206010007882 Cellulitis Diseases 0.000 description 3
- 208000009889 Herpes Simplex Diseases 0.000 description 3
- 206010021531 Impetigo Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000000505 pernicious effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960002163 hydrogen peroxide Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese preparation for treating skin diseases and process for preparation, wherein the medicament is prepared from the following constituents (by weight proportions): Chinese angelica root, astragalus root, notoginseng, corktree bark, ledebouriella root, dahurian angelica root, rhubarb horsetails, pubescent angelica root, licorice root, baikal skullcap root, flavescent sophora root, garden burnet root, curcuma longa, goldthread root, dipsacus root, root of red rooted saliva and panicled swallowwort root by the ratio of 9-32 : 9-40 : 5-15 : 10-40 : 3-25 : 10-40 : 9-40 : 10-35 : 5-10 : 10-40 : 10-40 : 9-40 : 6-25 : 3-15 : 9-40 : 15-50 : 6-30.
Description
Technical field
The invention belongs to technical field of Chinese medicine, relate in particular to dermopathic Chinese medicine of a kind of treatment and preparation method thereof.
Background technology
At present be to use the dosage forms such as ointment of doctor trained in Western medicine to treat for treating for skin disease, they exist certain side effect more, and what have treats halfway problem in addition, and cure rate is subjected to certain influence, and the also existence that has is easily recurred, problem repeatedly.
Summary of the invention
The purpose of this invention is to provide dermopathic Chinese medicine of a kind of treatment and preparation method thereof, have have no side effect, instant effect, distinguishing feature that cure rate is high.Be mainly used in various skin infection abscess class dermatosiss such as treatment burn and scald, various furuncle, scabies, scrofula.
The objective of the invention is to be achieved through the following technical solutions:
The dermopathic Chinese medicine of a kind of treatment, it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=9-32: 9-40: 5-15: 10-40: 3-25: 10-40: 9-40: 10-35: 5-10: 10-40: 10-40: 9-40: 6-25: 3-15: 9-40: 15-50: 6-30.
The dermopathic Chinese medicine of described a kind of treatment is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=32: 35: 15: 32: 25: 32: 32: 30: 10: 32: 32: 32: 25: 15: 32: 40: 25.
The dermopathic Chinese medicine of described a kind of treatment is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Cortex Phellodendri: Radix Et Rhizoma Rhei: Radix Scutellariae: Rhizoma Coptidis: Radix Sangusorbae :=9-32: 9-40: 10-40: 9-40: 10-40: 3-15: 9-40.
The dermopathic Chinese medicine of described a kind of treatment also can mix with an amount of Oleum Ricini, and the furnishing pasty state gets final product; Described Oleum Ricini can replace with Oleum sesami.
The dermopathic preparation method of Chinese medicine of a kind of treatment is characterized in that:
Get Radix Angelicae Sinensis, the Radix Astragali, Radix Notoginseng, Cortex Phellodendri, Radix Saposhnikoviae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Radix Angelicae Pubescentis, Radix Glycyrrhizae, Radix Scutellariae, Radix Sophorae Flavescentis, Radix Sangusorbae, Rhizoma Curcumae Longae, Rhizoma Coptidis, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Cynanchi Paniculati in described ratio, select clean, after the washing, oven dry, be ground to 80-200 purpose powder again, mixing and stirring, promptly.
The dermopathic preparation method of Chinese medicine of a kind of treatment is characterized in that:
Get Radix Angelicae Sinensis, the Radix Astragali, Cortex Phellodendri, Radix Et Rhizoma Rhei, Radix Scutellariae, Rhizoma Coptidis, Radix Sangusorbae in described ratio, select totally, after the washing, oven dry is ground to 80-200 purpose powder again, mixing and stirring, promptly.
Advantageous effect of the present invention is as follows:
The present invention is a raw material with pure Chinese medicine, and compatibility is reasonable, has easy to use, effective, instant effect, no pain, advantage that cure rate is high, and its cure rate can reach 99%, and without any side effect, and non-relapse after healing does not rebound to health of human body; Be particularly useful for treating that burn and scald injures that various furuncle, scabies, scrofula, incised wound are hemorrhage, eczema, herpes simplex, impetigo, herpes zoster, lupus erythematosus, furuncle cellulitis carbuncle, carbuncle lose various skin infection abscess class dermatosiss such as skin ulcer, expelling pus and promoting granulation for a long time; Also can effectively suppress pernicious skin infection and swell and ache, and significant curative effect is arranged.Have good market development potential, the treatment dermatosis is had extremely important meaning.
No valuable product among the present invention, used Chinese medicine source is sufficient, no in great shortage, and its preparation technology is easy to grasp, and is safe and reliable, has no side effect, and the curative effect height is easy to apply.
Clinical trial curative effect of medication visual report of the present invention
To observe further proof medicine of the present invention---curative effect and the practicality and the creativeness of " detumescence and drawing out poison looses " by clinical case below, is example by the inventor through two during the last ten years clinical treatment cases, 200 examples suffered from eczema, furuncle, scabies, scrofula, incised wound is hemorrhage, herpes zoster, various skin infection abscess such as lupus erythematosus class dermatosis patient carries out clinical trial, the state of an illness patient, disease time, and doctor's technical conditions equate or proximate situation under, compare, and carry out clinical observation, prove that curative effect of medication of the present invention is remarkable, the effective percentage height, short treating period now is reported as follows observed result:
One, test method: take random packet, the controlled trial method.With various skin case random packet, be divided into test group: Chinese medicine of the present invention---detumescence and drawing out poison looses and organizes; Matched group: Herba Sidae Szechuensis group, the Herba Sidae Szechuensis of selecting for use Kang An pharmaceutical factory to produce; Each group is chosen 100 examples respectively.
Two, case: each is organized sex, age and sees Table 1.Disease type sees Table 2.
Three, dosage and method:
1, test group:
Medication: detumescence and drawing out poison looses.
Dosage form: powder, 50 gram/bags.
Usage:, every day 2-3 time, be applied in the affected part according to the wound surface area.
The course of treatment: 3-15 days.
2, matched group:
Medication: Herba Sidae Szechuensis.
Dosage form: powder, 50 gram/bags.
Usage:, every day 2-3 time, be applied in the affected part according to the wound surface area.
The course of treatment: 7-30 days is a course of treatment.
Four, criterion of therapeutical effect and judgement:
1, criterion of therapeutical effect:
Recovery from illness: various skin infection abscess symptom complete obiterations such as eczema, furuncle, scabies, scrofula, incised wound are hemorrhage, herpes zoster, lupus erythematosus.
Produce effects: eczema, furuncle, scabies, scrofula, incised wound are hemorrhage, various skin infection abscess symptoms are most of disappears for herpes zoster, lupus erythematosus etc.
Invalid: various skin infection abscess doing well,improvings such as eczema, furuncle, scabies, scrofula, incised wound are hemorrhage, herpes zoster, lupus erythematosus are not obvious.
2, therapeutic outcome is judged:
Efficient statistics, and significance relatively: test group and matched group see table 3,4,5 for details than the comparison sheet of the curative effect difference statistical processing methods with the x2 test.
Check through x2, the total effective rate 99% of test group, matched group total effective rate are 84%, test group and matched group curative effect significant difference.
Five, conclusion
The effectively comparative analysis course of treatment: test group treatment time is 3-15 days, and what reach total effectively standard is 99%.
Matched group: treatment time is 7-30 days, and what reach effective standard accounts for 84%, test group and matched group significant difference.
From this group clinical statistics, the total effective rate of medicine of the present invention " detumescence and drawing out poison loose " is at hemorrhage, the lupus erythematosus of observing time internal therapy eczema, furuncle, scabies, scrofula, incised wound, herpes zoster total effective rate average out to 99%; And matched group is at hemorrhage, the lupus erythematosus of observing time internal therapy eczema, furuncle, scabies, scrofula, incised wound, herpes zoster total effective rate average out to 84%.
Statistical analysis is handled: both effective percentage have significant difference, and the therapeutic effect of test group is good, instant effect, and short treating period is better than the matched group medicine.
Six, untoward reaction:
Use clinical drug of the present invention 100 routine patients are carried out complete observation, any untoward reaction was not all found in medication patient therebetween.
Seven, clinical experience:
By adopting the dermopathic Chinese medicine of Drug therapy of the present invention, received satisfied curative effect.Because the disease of skin class disease is a lot, this clinical trial selects that modal eczema, furuncle, scabies, scrofula, incised wound are hemorrhage, lupus erythematosus, herpes zoster, and clinical treatment is to make a definite diagnosis in general hospital and section hospital's diagnosis to belong to above-mentioned disease and test.
According to efficient statistics, the total effective rate 99% of test group, matched group total effective rate are 84%, test group and matched group curative effect significant difference, and matched group is very low to burn and scald disease curative effect.Therefore, the therapeutic effect of test group is fast, and short treating period is better than the matched group medicine.
Show that according to test skin disorders such as medicine of the present invention is hemorrhage to common eczema, furuncle, scabies, scrofula, incised wound, lupus erythematosus, herpes zoster have certain treatment and imitate, and therapeutic effect is remarkable, is better than the matched group medicine.
Medicine of the present invention is used dialectical the executing of theory of Chinese medical science and is controlled, and carries out the integral body conditioning, and the patient does not have any toxicity, no skin allergy, and fast to the indication curative effect, effect is remarkable, and its effective percentage reaches 99%.Patient after more than curing through return visit have more than 2 years, not have discovery that the case of recurrence is arranged.
Eight, below will observe further proof medicine of the present invention by clinical case---curative effect and the practicality and the creativeness of " detumescence and drawing out poison looses " burn and scald proprietary formula, especially carry out clinical trial at treatment case 100 examples of scalding of cooking, in patient's the state of an illness, disease time, and doctor's technical conditions equate or proximate situation under, compare, and carry out clinical observation, prove that curative effect of medication of the present invention is remarkable, the effective percentage height, short treating period now is reported as follows observed result:
1, test method: choose burn and scald case 100 examples, the prescription Chinese medicine that uses the present invention to treat the burn and scald special use carries out the medication test.
2, case: sex, age see Table 6 in 100 examples of test group:
3, dosage and method:
Medication: detumescence and drawing out poison looses, and controls the burn and scald proprietary formula.
Dosage form: powder, 50 gram/bags.
Usage:, every day 2-3 time, be applied in the affected part according to the wound surface area.
The course of treatment: 3-15 days.
4, treatment standard:
Recovery from illness: various symptom complete obiterations such as burn and scald.
Produce effects: various symptoms such as burn and scald are most of to disappear.
Invalid: various doing well,improvings such as burn and scald are not obvious.
5, therapeutic outcome is judged: see table 7 for details.
Through checking, the various symptoms of burn and scald group use detumescence and drawing out poison to loose---and the time of burn and scald proprietary formula is generally and can reaches ideal effect in 3-15 days, total effective rate through evidence burn and scald group reaches 99%, and it is evident in efficacy to be higher than like product on sale in the market.
6, conclusion
From this group clinical statistics, medicine of the present invention " detumescence and drawing out poison looses "---the total effective rate of treatment burn and scald proprietary formula is at the total effective rate average out to 99% of internal therapy burn and scald observing time.Therapeutic effect is good, instant effect, and short treating period is better than the medicine of like product.
7, untoward reaction:
Use that Drug therapy burn and scald proprietary formula of the present invention is clinical to carry out complete observation to 100 routine patients, any untoward reaction was not all found in medication patient therebetween.
8, clinical experience:
By adopting the dermopathic treatment by Chinese herbs burn and scald of Drug therapy of the present invention proprietary formula, received satisfied curative effect.According to efficient statistics, the total effective rate 99% of treatment burn and scald, therefore, the therapeutic effect of burn and scald group is fast, and short treating period is better than similar medicine.
Medicine of the present invention is used dialectical the executing of theory of Chinese medical science and is controlled, and carries out the integral body conditioning, and the patient does not have any toxicity, no skin allergy, and fast to the indication curative effect, effect is remarkable, and its effective percentage reaches 99%.Patient after more than curing through return visit have more than 2 years, recovery effects is good, not have discovery that the case of recurrence is arranged.
Nine, cure mainly
Cure mainly: be applicable to that the treatment burn and scald injures that various furuncle, scabies, scrofula, incised wound are hemorrhage, eczema, herpes simplex, impetigo, herpes zoster, lupus erythematosus, furuncle cellulitis carbuncle, carbuncle lose various skin infection abscess class dermatosiss such as skin ulcer, expelling pus and promoting granulation for a long time; Also can effectively suppress pernicious skin infection swells and ache.
Describe the present invention in detail below in conjunction with embodiment:
The specific embodiment
Embodiment 1:
The dermopathic Chinese medicine of a kind of treatment is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=9: 9: 5: 10: 3: 10: 9: 10: 5: 10: 10: 9: 6: 3: 9: 15: 6.
Its preparation method is:
Get Radix Angelicae Sinensis 90g according to the above ratio, Radix Astragali 90g, Radix Notoginseng 50g, Cortex Phellodendri 100g, Radix Saposhnikoviae 30g, Radix Angelicae Dahuricae 100g, Radix Et Rhizoma Rhei 90g, Radix Angelicae Pubescentis 100g, Radix Glycyrrhizae 50g, Radix Scutellariae 100g, Radix Sophorae Flavescentis 100g, Radix Sangusorbae 90g, Rhizoma Curcumae Longae 60g, Rhizoma Coptidis 30g, Radix Dipsaci 90g, Radix Salviae Miltiorrhizae 150g, the above-mentioned medicated powder of Radix Cynanchi Paniculati 60g is selected totally, after the washing, and oven dry, be ground to 80 purpose powder again, mixing and stirring, promptly.
Must disinfect earlier before each medication, available hydrogenperoxide steam generator carries out disinfection, and then powder of the present invention directly is dispersed in injured last getting final product.
When wound surface has lymph water excessive, then should be sprinkling upon the surface with dried powder earlier, wait the incrustation back mixing with above-mentioned powder with an amount of Oleum Ricini or Oleum sesami, the furnishing pasty state that stirs applies uniformly in the injury every day 2-3 time.
We are applicable to that treatment various furuncle, scabies, scrofula, incised wound are hemorrhage, eczema, herpes simplex, impetigo, herpes zoster, lupus erythematosus, furuncle cellulitis carbuncle, carbuncle lose various skin infection abscess class dermatosiss such as skin ulcer, expelling pus and promoting granulation for a long time; Also can effectively suppress the effect that pernicious skin infection swells and ache.
Embodiment 2:
The dermopathic Chinese medicine of a kind of treatment, it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=25: 28: 10: 25: 15: 25: 25: 25: 8: 25: 25: 25: 15: 10: 25: 35: 20.
Its preparation method is:
Get Radix Angelicae Sinensis 250g according to the above ratio, Radix Astragali 280g, Radix Notoginseng 100g, Cortex Phellodendri 250g, Radix Saposhnikoviae 150g, Radix Angelicae Dahuricae 250g, Radix Et Rhizoma Rhei 250g, Radix Angelicae Pubescentis 250g, Radix Glycyrrhizae 80g, Radix Scutellariae 250g, Radix Sophorae Flavescentis 250g, Radix Sangusorbae 250g, Rhizoma Curcumae Longae 150g, Rhizoma Coptidis 100g, Radix Dipsaci 250g, Radix Salviae Miltiorrhizae 350g, the above-mentioned medicated powder of Radix Cynanchi Paniculati 200g is selected totally, after the washing, and oven dry, be ground to 120 purpose powder again, mixing and stirring, promptly.
Other is with embodiment 1
Embodiment 3:
The dermopathic Chinese medicine of a kind of treatment, it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=32: 35: 15: 32: 25: 32: 32: 30: 10: 32: 32: 32: 25: 15: 32: 40: 25.
Its preparation method is:
Get Radix Angelicae Sinensis 320g according to the above ratio, Radix Astragali 350g, Radix Notoginseng 150g, Cortex Phellodendri 320g, Radix Saposhnikoviae 250g, Radix Angelicae Dahuricae 320g, Radix Et Rhizoma Rhei 320g, Radix Angelicae Pubescentis 300g, Radix Glycyrrhizae 100g, Radix Scutellariae 320g, Radix Sophorae Flavescentis 320g, Radix Sangusorbae 320g, Rhizoma Curcumae Longae 250g, Rhizoma Coptidis 150g, Radix Dipsaci 320g, Radix Salviae Miltiorrhizae 400g, the above-mentioned medicated powder of Radix Cynanchi Paniculati 250g is selected totally, after the washing, and oven dry, be ground to 200 purpose powder again, mixing and stirring, promptly.
Other is with embodiment 1
Embodiment 4:
The dermopathic Chinese medicine of a kind of treatment, it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=32: 40: 15: 40: 25: 40: 40: 35: 10: 40: 40: 40: 25: 15: 40: 50: 30.
Its preparation method is:
Get Radix Angelicae Sinensis 320g according to the above ratio, Radix Astragali 400g, Radix Notoginseng 150g, Cortex Phellodendri 400g, Radix Saposhnikoviae 250g, Radix Angelicae Dahuricae 400g, Radix Et Rhizoma Rhei 400g, Radix Angelicae Pubescentis 350g, Radix Glycyrrhizae 100g, Radix Scutellariae 400g, Radix Sophorae Flavescentis 400g, Radix Sangusorbae 400g, Rhizoma Curcumae Longae 250g, Rhizoma Coptidis 150g, Radix Dipsaci 400g, Radix Salviae Miltiorrhizae 500g, the above-mentioned medicated powder of Radix Cynanchi Paniculati 300g is selected totally, after the washing, and oven dry, be ground to 100 purpose powder again, mixing and stirring, promptly.
Other is with embodiment 1
Embodiment 5:
The dermopathic Chinese medicine of a kind of treatment, special for treating burn and scald prescription is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Cortex Phellodendri: Radix Et Rhizoma Rhei: Radix Scutellariae: Rhizoma Coptidis: Radix Sangusorbae=9: 9: 10: 9: 10: 3: 9.
Its preparation method is: get Radix Angelicae Sinensis 90g, Radix Astragali 90g, Cortex Phellodendri 100g, Radix Et Rhizoma Rhei 90g, Radix Scutellariae 100g, Rhizoma Coptidis 30g, Radix Sangusorbae 90g according to the above ratio, select totally, after the washing, 200 purpose powder are ground in oven dry again, mixing and stirring, promptly.
Must disinfect earlier before each medication, available hydrogenperoxide steam generator carries out disinfection, and then powder of the present invention directly is dispersed in injured last getting final product.
During use, mix with above-mentioned powder with an amount of Oleum Ricini or Oleum sesami after wound has been done or formed a scab, the furnishing pasty state that stirs applies uniformly in the injury every day 2-3 time.
We are applicable to the various burn and scald of treatment.
Embodiment 6:
The dermopathic Chinese medicine of a kind of treatment, special for treating burn and scald prescription is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Cortex Phellodendri: Radix Et Rhizoma Rhei: Radix Scutellariae: Rhizoma Coptidis: Radix Sangusorbae=20: 30: 30: 30: 30: 10: 30.
Its preparation method is:
Get Radix Angelicae Sinensis 20g, Radix Astragali 30g, Cortex Phellodendri 30g, Radix Et Rhizoma Rhei 30g, Radix Scutellariae 30g, Rhizoma Coptidis 10g, Radix Sangusorbae 30g according to the above ratio, select totally, after the washing, 100 purpose powder are ground in oven dry again, mixing and stirring, promptly.
Other is with embodiment 5.
Embodiment 7:
The dermopathic Chinese medicine of a kind of treatment, special for treating burn and scald prescription is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Cortex Phellodendri: Radix Et Rhizoma Rhei: Radix Scutellariae: Rhizoma Coptidis: Radix Sangusorbae=32: 40: 40: 40: 40: 15: 40.
Its preparation method is:
Get Radix Angelicae Sinensis 32g, Radix Astragali 40g, Cortex Phellodendri 40g, Radix Et Rhizoma Rhei 40g, Radix Scutellariae 40g, Rhizoma Coptidis 15g, Radix Sangusorbae 40g according to the above ratio, select totally, after the washing, 200 purpose powder are ground in oven dry again, mixing and stirring, promptly.
Other is with embodiment 5.
Each test group sex of table 1, age
| Group | Total routine number | Age | Sex | ||||
| 6-30 | 30-40 | 40-60 | More than 60 | The man | The woman | ||
| Test group | 100 | 20 | 20 | 30 | 30 | 50 | 50 |
| Matched group | 100 | 10 | 30 | 30 | 30 | 50 | 50 |
| Add up to | 200 | 30 | 50 | 60 | 60 | 100 | 100 |
Table 2 disease symptoms
The efficient statistics of table 3
| Group | Total routine number | Recovery from illness | Produce effects | Invalid | Total effective rate | |||
| Example | ％ | Example | ％ | Example | ％ | |||
| Test group | 100 | 97 | 97 | 2 | 2 | 1 | 1 | 99％ |
| Matched group | 100 | 75 | 75 | 9 | 9 | 16 | 16 | 84％ |
The various symptoms of table 4 test group are used diffusing time of detumescence and drawing out poison and curative effect detail list
The various symptoms of table 5 matched group are used Herba Sidae Szechuensis time and curative effect detail list
Sex, the age statistical table of table 6 burn and scald group case
| Group | Total routine number | Age | Sex | ||||
| 6-30 | 30-40 | 40-60 | More than 60 | The man | The woman | ||
| The burn and scald group | 100 | 20 | 20 | 30 | 30 | 50 | 50 |
The efficient statistics of table 7:
| Group | Total routine number | Recovery from illness | Produce effects | Invalid | Total effective rate | |||
| Example | ％ | Example | ％ | Example | ％ | |||
| The burn and scald group | 100 | 98 | 98 | 1 | 1 | 1 | 1 | 99％ |
Claims (6)
1, the dermopathic Chinese medicine of a kind of treatment is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=9-32: 9-40: 5-15: 10-40: 3-25: 10-40: 9-40: 10-35: 5-10: 10-40: 10-40: 9-40: 6-25: 3-15: 9-40: 15-50: 6-30.
2, the dermopathic Chinese medicine of a kind of treatment according to claim 1 is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Radix Notoginseng: Cortex Phellodendri: Radix Saposhnikoviae: the Radix Angelicae Dahuricae: Radix Et Rhizoma Rhei: Radix Angelicae Pubescentis: Radix Glycyrrhizae: Radix Scutellariae: Radix Sophorae Flavescentis: Radix Sangusorbae: Rhizoma Curcumae Longae: Rhizoma Coptidis: Radix Dipsaci: Radix Salviae Miltiorrhizae: Radix Cynanchi Paniculati=32: 35: 15: 32: 25: 32: 32: 30: 10: 32: 32: 32: 25: 15: 32: 40: 25.
3, the dermopathic Chinese medicine of a kind of treatment according to claim 1 and 2 is characterized in that it is formulated by weight by following component:
Radix Angelicae Sinensis: the Radix Astragali: Cortex Phellodendri: Radix Et Rhizoma Rhei: Radix Scutellariae: Rhizoma Coptidis: Radix Sangusorbae=9-32: 9-40: 10-40: 9-40: 10-40: 3-15: 9-40.
4, according to claim 1 or the dermopathic Chinese medicine of 2 or 3 described a kind of treatments, it is characterized in that also can mixing with an amount of Oleum Ricini according to claim 1 or 2 or 3 described Chinese medicines, the furnishing pasty state gets final product; Described Oleum Ricini can replace with Oleum sesami.
5, the dermopathic preparation method of Chinese medicine of a kind of treatment is characterized in that:
Get Radix Angelicae Sinensis, the Radix Astragali, Radix Notoginseng, Cortex Phellodendri, Radix Saposhnikoviae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Radix Angelicae Pubescentis, Radix Glycyrrhizae, Radix Scutellariae, Radix Sophorae Flavescentis, Radix Sangusorbae, Rhizoma Curcumae Longae, Rhizoma Coptidis, Radix Dipsaci, Radix Salviae Miltiorrhizae, Radix Cynanchi Paniculati by aforesaid right requirement 1 or 2 described ratios, select clean, after the washing, oven dry, be ground to 80-200 purpose powder again, mixing and stirring, promptly.
6, the dermopathic preparation method of Chinese medicine of a kind of treatment is characterized in that:
Get Radix Angelicae Sinensis, the Radix Astragali, Cortex Phellodendri, Radix Et Rhizoma Rhei, Radix Scutellariae, Rhizoma Coptidis, Radix Sangusorbae by aforesaid right requirement 3 described ratios, select totally, after the washing, oven dry is ground to 80-200 purpose powder again, mixing and stirring, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710011491XA CN101062361B (en) | 2007-05-29 | 2007-05-29 | Chinese traditional medicine for treating dermatosis and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710011491XA CN101062361B (en) | 2007-05-29 | 2007-05-29 | Chinese traditional medicine for treating dermatosis and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101062361A true CN101062361A (en) | 2007-10-31 |
| CN101062361B CN101062361B (en) | 2011-04-13 |
Family
ID=38963778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710011491XA Expired - Fee Related CN101062361B (en) | 2007-05-29 | 2007-05-29 | Chinese traditional medicine for treating dermatosis and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101062361B (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101357190B (en) * | 2008-09-16 | 2010-12-29 | 张传华 | Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| CN101391066B (en) * | 2008-11-04 | 2011-01-26 | 唐武 | Traditional Chinese medicine decoction for treating psoriasis |
| CN101491614B (en) * | 2008-11-27 | 2011-04-20 | 北京宏泰康达医药科技有限公司 | Traditional Chinese medicine composition for treating mouth and tongue sore and stomatocace |
| CN101584773B (en) * | 2009-06-10 | 2011-05-11 | 张学贵 | Chinese herbal medicament for treating skin diseases |
| CN102302605A (en) * | 2011-08-27 | 2012-01-04 | 邱建华 | Angelica dahurica, goldthread and Chinese angelica powder for cracked nipple |
| CN102631572A (en) * | 2012-04-03 | 2012-08-15 | 司琴英 | Method for preparing traditional Chinese medicine (TCM) lotion for treating hemorrhagic pustule on sole |
| CN103933521A (en) * | 2014-04-23 | 2014-07-23 | 山西省生态畜牧产业管理站 | Traditional Chinese medicine preparation for treating ringworm of sheep |
| CN104398974A (en) * | 2014-11-11 | 2015-03-11 | 合肥不老传奇保健科技有限公司 | External traditional Chinese medicine for treating furunculosis |
| CN104645157A (en) * | 2015-01-29 | 2015-05-27 | 陈文斌 | External application agent for removing burns and scalds scars and preparation method of external application agent |
| CN104940849A (en) * | 2015-07-29 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine preparation for treating boils through external application and preparation method of traditional Chinese medicine preparation |
| CN105963525A (en) * | 2016-05-24 | 2016-09-28 | 张鸿梅 | Scabies treatment external ointment |
| CN106074224A (en) * | 2016-06-29 | 2016-11-09 | 田东县浙缘农业科技有限公司 | A kind of removing acnes and controlling oil facial film water and preparation method thereof |
| CN108542933A (en) * | 2018-06-05 | 2018-09-18 | 王福珍 | A kind of antibacterial anti-inflammatory Chinese medicine composition and preparation method thereof |
| CN108904627A (en) * | 2018-08-28 | 2018-11-30 | 王峰 | burn and scald skin antibacterial liquid |
| CN110201095A (en) * | 2019-07-12 | 2019-09-06 | 戚春直 | It is a kind of for treating the Chinese medicine composition and preparation method thereof of burn |
| CN111067984A (en) * | 2020-01-15 | 2020-04-28 | 吕志强 | Compound external traditional Chinese medicine coating liquid for treating skin ulcer and preparation method and application thereof |
| CN111529644A (en) * | 2020-03-13 | 2020-08-14 | 李迎春 | Lingqi Sanhuang plaster |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1262943A (en) * | 1999-02-09 | 2000-08-16 | 夏进 | Skin ointment with functions of relieving inflammation, alleviating pain and inhibiting cicatrization |
| CN1282596A (en) * | 2000-07-27 | 2001-02-07 | 赵凤山 | Baiyinggao for treating internal and external injuries |
-
2007
- 2007-05-29 CN CN200710011491XA patent/CN101062361B/en not_active Expired - Fee Related
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101357190B (en) * | 2008-09-16 | 2010-12-29 | 张传华 | Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| CN101391066B (en) * | 2008-11-04 | 2011-01-26 | 唐武 | Traditional Chinese medicine decoction for treating psoriasis |
| CN101491614B (en) * | 2008-11-27 | 2011-04-20 | 北京宏泰康达医药科技有限公司 | Traditional Chinese medicine composition for treating mouth and tongue sore and stomatocace |
| CN101584773B (en) * | 2009-06-10 | 2011-05-11 | 张学贵 | Chinese herbal medicament for treating skin diseases |
| CN102302605A (en) * | 2011-08-27 | 2012-01-04 | 邱建华 | Angelica dahurica, goldthread and Chinese angelica powder for cracked nipple |
| CN102631572A (en) * | 2012-04-03 | 2012-08-15 | 司琴英 | Method for preparing traditional Chinese medicine (TCM) lotion for treating hemorrhagic pustule on sole |
| CN103933521B (en) * | 2014-04-23 | 2016-08-24 | 山西省生态畜牧产业管理站 | The Chinese medicine preparation for the treatment of sheep tinea circinata |
| CN103933521A (en) * | 2014-04-23 | 2014-07-23 | 山西省生态畜牧产业管理站 | Traditional Chinese medicine preparation for treating ringworm of sheep |
| CN104398974A (en) * | 2014-11-11 | 2015-03-11 | 合肥不老传奇保健科技有限公司 | External traditional Chinese medicine for treating furunculosis |
| CN104645157A (en) * | 2015-01-29 | 2015-05-27 | 陈文斌 | External application agent for removing burns and scalds scars and preparation method of external application agent |
| CN104940849A (en) * | 2015-07-29 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine preparation for treating boils through external application and preparation method of traditional Chinese medicine preparation |
| CN105963525A (en) * | 2016-05-24 | 2016-09-28 | 张鸿梅 | Scabies treatment external ointment |
| CN106074224A (en) * | 2016-06-29 | 2016-11-09 | 田东县浙缘农业科技有限公司 | A kind of removing acnes and controlling oil facial film water and preparation method thereof |
| CN108542933A (en) * | 2018-06-05 | 2018-09-18 | 王福珍 | A kind of antibacterial anti-inflammatory Chinese medicine composition and preparation method thereof |
| CN108904627A (en) * | 2018-08-28 | 2018-11-30 | 王峰 | burn and scald skin antibacterial liquid |
| CN110201095A (en) * | 2019-07-12 | 2019-09-06 | 戚春直 | It is a kind of for treating the Chinese medicine composition and preparation method thereof of burn |
| CN111067984A (en) * | 2020-01-15 | 2020-04-28 | 吕志强 | Compound external traditional Chinese medicine coating liquid for treating skin ulcer and preparation method and application thereof |
| CN111529644A (en) * | 2020-03-13 | 2020-08-14 | 李迎春 | Lingqi Sanhuang plaster |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101062361B (en) | 2011-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062361A (en) | Chinese traditional medicine for treating dermatosis and its preparation method | |
| CN1907358A (en) | Pharmaceutical composition for preventing and treating avian coccidiosis and its preparing method | |
| CN1876144A (en) | A Chinese medicine for treating skin disease of fur-bearing animal and preparation process thereof | |
| CN1895490A (en) | Production of Chinese medicine and its medicinal pillow for treating cervical spondylosis | |
| CN102670770B (en) | Compound propolis pure Chinese medicinal composition for treating white scour of piglets and preparation method thereof | |
| CN101049337A (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN101040957A (en) | Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same | |
| CN1864730A (en) | A cancer-treating medicine | |
| CN1293896C (en) | Medication for treating primary disease of purpura haemorhagica and preparation method | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1130217C (en) | Medicine for preventing and treating cancer and preparation process thereof | |
| CN1293897C (en) | Burn and scald treating powder | |
| CN1679658A (en) | Chinese medicine preparation for treating AIDS and process thereof | |
| CN102274326B (en) | Pure Chinese medicinal combination for treating piglet yellow-white dysentery and preparation method thereof | |
| CN1104906A (en) | "Futongning" health bag | |
| CN1840101A (en) | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof | |
| CN1686488A (en) | Medicine for treating malignant tumour and its production method | |
| CN1186028C (en) | Antagesic Chinese medicine and its preparing process and usage | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN102961515A (en) | Compound propolis combination for treating swine erysipelas and preparation method of combination | |
| CN1238011C (en) | Medicine for preventing and treating fowl pox | |
| CN1110598A (en) | Hot application for stopping cancer pain | |
| CN102397533A (en) | Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof | |
| CN1232274C (en) | Composite medicine for prevention and cure of osteoporosis and its application | |
| CN1583015A (en) | Chinese medicine for angina pectoris and preventing from diseases of cerebral blood vessels and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHAO SHULAN Free format text: FORMER OWNER: ZHAO SULAN Effective date: 20110418 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110141 ZHAO SULAN (CARE OF) WANG JIALU, HONGQITAI VILLAGE, YUHONG TOWNSHIP,YUHONG DISTRICT, SHENYANG CITY, LIAONING PROVINCE TO: 110149 (RECEIVED BY) ZHAO SHULAN, ROOM 602, UNIT 5, BUILDING 9, HETANG YUESE RESIDENTIAL QUARTER, XINGUANG VILLAGE, DAXING TOWNSHIP, YUHONG DISTRICT, SHENYANG CITY, LIAONING PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110418 Address after: 110149, Shenyang, Liaoning Province, Yuhong District, Tai Hing township, Xinguang village, lotus pond District, building 9, room 5, room 602, Zhao Shulan Applicant after: Zhao Shulan Address before: 110141 Wang Jialu transfer to Zhao Sulan village, Hongqi village, Hung Heung, Yuhong District, Shenyang, Liaoning Applicant before: Zhao Sulan |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110413 Termination date: 20160529 |